These herbal products should not be available but are sold on U.S. Web sites for gastrointestinal symptoms, weight loss, cough, and immune stimulation.
The toxicologic evidence of the risks associated with aristolochic acid is strong. In 1982, tumors were rapidly induced in rats at low doses 5 ; aristolochic acid is among the most potent 2 percent of the carcinogens in our Carcinogenic Potency Database. 6 It is mutagenic, forms DNA adducts in humans, and is carcinogenic in mice. 3 In rabbits, aristolochic acid induces nephrotoxic effects, the same DNA adducts in kidney as in humans, and urothelial tumors. 3 The availability of aristolochic acid-containing products on the Web two years after an FDA alert was issued reveals a serious flaw in the safety protection afforded the public. Under the Dietary Supplement Health Education Act, herbal products do not require FDA approval of efficacy or safety before marketing, and products are not registered. In addition, the Web is a marketing tool with low barriers to entry (anyone can set up a Web site inexpensively). The failure to protect the public from the imminent hazard of aristolochic acid indicates that there is an urgent need to remove these products from the Web
